← Browse by Condition
Medical Condition

critical care

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for critical care sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — critical care Clinical Trials

How many clinical trials are currently recruiting for critical care?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for critical care, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for critical care?
critical care research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a critical care clinical trial?
Eligibility criteria for critical care trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Weill Medical College of Cornell University 1 trial
Universita degli Studi di Genova 1 trial
Lady Davis Institute 1 trial
Medipol University 1 trial
Capital Medical University 1 trial

Recruiting Clinical Trials

NCT05587517 Phase 2
Recruiting
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Enrollment
172 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07093125
Recruiting
Rehabilitation Practices in Critically Ill Patients Receiving Invasive Mechanical Ventilation in the Intensive Care Unit.
Enrollment
2,400 pts
Location
Italy
Sponsor
Universita degli Studi di Geno...
View Trial →
NCT05659485
Recruiting
Measuring Family Engagement in Care (The FAME Study)
Enrollment
198 pts
Location
Canada
Sponsor
Lady Davis Institute
View Trial →
NCT07420946
Recruiting
Mechanical Insufflation-Exsufflation in Critically Ill Patients
Enrollment
30 pts
Location
Italy, Spain, Turkey...
Sponsor
Medipol University
View Trial →
NCT06526598
Recruiting
Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
Enrollment
619 pts
Location
China
Sponsor
Capital Medical University
View Trial →

Related Conditions

grief (1) trauma (1) psychotherapy (1) mechanical ventilation (1) pulmonary rehabilitation (1) intensive care units icus (1) quality of life qol (1) outcome assessment (1) extubation failure (1) mortality (1) family engagement (1) patient centered care (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology